Bulletin Updates
Amneal plans Rs.997-crore greenfield API plant near Ahmedabad – 20 May 2026
May 20, 2026
An environmental study reveals Amneal Biopharma's nearly Rs.1,000-crore peptide and Glatiramer Acetate facility in Gujarat.
A small-volume, high-value API project aims to put complex molecules on the Bavla map.
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »